FDA: Auvi-Q epinephrine injection recalled

Posted in Latest News on October 30, 2015.

Under a voluntary recall, Sanofi US has recalled all Auvi-Q products on the market in both 0.15 mg and 0.3 mg because of suspected device malfunctions, the FDA announced this week. The product is available to hospitals, retailers and customers.

According to the FDA announcement, the product can deliver the wrong dosage. A patient experiencing allergic reaction could die if the proper dosage is not used.
For more information on lot numbers and product descriptions, see the FDA release:www.fda.gov/Safety/Recalls/ucm469980.htm



More Latest News

Executive Order regarding the state of Florida
October 3, 2017

Due to impacts from Hurricane Maria Governor Scott has issued an executive order regarding the state of Florida Continue reading


Fingerprint Retention Requirements
September 27, 2017

Florida statute requires individuals who were fingerprinted on or after Jan. 1, 2013 to have their background results retained in Florida’s Care Provider Background Screening Clearinghouse. Continue reading